Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 104177
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.104177
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.104177
Table 3 Comparison of general data of pregnant women with different perinatal outcomes
Parameter | Normal perinatal outcome | Adverse perinatal outcome (n = 37) | χ2/t | P value |
Age (years) | 28.66 ± 3.26 | 29.24 ± 3.76 | 0.869 | 0.387 |
Pre-pregnancy BMI (kg/m2) | 22.11 ± 2.14 | 22.21 ± 2.17 | 0.238 | 0.812 |
Parity (time) | 3.965 | 0.138 | ||
0 | 33 | 20 | ||
1 | 51 | 14 | ||
≥ 2 | 5 | 3 | ||
Gestational age at delivery (weeks) | 38.27 ± 0.75 | 38.31 ± 0.71 | 0.277 | 0.782 |
Newborn body mass (g) | 3677 ± 335 | 3663 ± 347 | 0.211 | 0.833 |
Adverse outcome | - | - | ||
Newborn birth weight does not correspond to the week of gestation | - | 9 | ||
Congenital dysplasia | - | 6 | ||
Birth injury | - | 3 | ||
Neonatal asphyxia | - | 6 | ||
Newborns hypoglycemia | - | 4 | ||
Neonatal ultrasound or neonatal electrocardiogram abnormalities | - | 6 | ||
Neonatal neurobehavioral score < 35 points | - | 3 | ||
History of smoking | 6 | 6 | 2.723 | 0.099 |
History of drinking | 10 | 8 | 2.302 | 0.129 |
Family history of diabetes | 22 | 14 | 2.204 | 0.138 |
FPG | ||||
At 24-28 weeks of pregnancy | 5.51 ± 0.32 | 5.47 ± 0.33 | 0.633 | 0.528 |
Before delivery | 4.77 ± 0.38 | 4.83 ± 0.48 | 0.745 | 0.457 |
HbA1c (%) | ||||
At 24-28 weeks of pregnancy | 6.06 ± 0.28 | 6.04 ± 0.32 | 0.350 | 0.727 |
Before delivery | 5.56 ± 0.52 | 5.50 ± 0.38 | 0.634 | 0.527 |
TC (mmol/L) | ||||
At 24-28 weeks of pregnancy | 5.42 ± 0.36 | 5.51 ± 0.38 | 1.257 | 0.211 |
Before delivery | 5.98 ± 0.39 | 5.89 ± 0.34 | 1.223 | 0.224 |
TG (mmol/L) | ||||
At 24-28 weeks of pregnancy | 2.94 ± 0.21 | 2.92 ± 0.22 | 0.480 | 0.632 |
Before delivery | 3.18 ± 0.37 | 3.19 ± 0.35 | 0.140 | 0.889 |
HDL-C (mmol/L) | ||||
At 24-28 weeks of pregnancy | 1.70 ± 0.29 | 1.72 ± 0.35 | 0.331 | 0.741 |
Before delivery | 1.86 ± 0.24 | 1.81 ± 0.35 | 0.924 | 0.357 |
LDL-C (mmol/L) | ||||
At 24-28 weeks of pregnancy | 3.64 ± 0.45 | 3.60 ± 0.54 | 0.428 | 0.669 |
Before delivery | 3.84 ± 0.48 | 3.89 ± 0.46 | 0.539 | 0.591 |
AGE (ng/L) | ||||
At 24-28 weeks of pregnancy | 436.22 ± 56.73 | 525.93 ± 38.75 | 8.795 | < 0.00011 |
Before delivery | 445.23 ± 53.78 | 541.10 ± 51.51 | 9.225 | < 0.00011 |
sRAGE (ng/L) | ||||
At 24-28 weeks of pregnancy | 295.75 ± 36.52 | 255.70 ± 28.03 | 5.973 | < 0.00011 |
Before delivery | 275.72 ± 33.17 | 254.18 ± 24.51 | 3.563 | < 0.0011 |
SOD (U/L) | ||||
At 24-28 weeks of pregnancy | 83.94 ± 3.18 | 82.16 ± 3.06 | 2.898 | 0.0051 |
Before delivery | 80.76 ± 2.81 | 79.10 ± 3.39 | 2.284 | 0.0051 |
MDA (μmol/L) | ||||
At 24-28 weeks of pregnancy | 4.63 ± 0.64 | 5.12 ± 0.75 | 3.667 | < 0.0011 |
Before delivery | 5.09 ± 0.89 | 5.56 ± 0.70 | 2.877 | 0.0051 |
- Citation: Zhang Y, Li T, Wang ZH, Liu Y. Correlation between serum advanced glycation end-products and their receptor-mediated oxidative stress and perinatal outcomes in gestational diabetes mellitus. World J Diabetes 2025; 16(6): 104177
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/104177.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.104177